Riskpilot← Back to searchSign inGet full accessAspirus Hälsovård AB
ABActiveOrg 5569810822Ölmevägen 30General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2024
SEK 998K
+68% vs 2023
EBITDA margin
-11.0%
-187% vs 2023
Equity ratio
90.3%
Financial strength
Net profit 2024
SEK -110K
-209% vs 2023
| Revenue | SEK 998K | +68% |
| EBITDA | SEK -110K | -187% |
| Net profit | SEK -110K | -209% |
| Total assets | SEK 288K | -28% |
| Equity | SEK 260K | -30% |
| Employees | 0 | — |
Legal name
Aspirus Hälsovård AB
Org number
5569810822
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 augusti 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Allmän öppen hälso- och sjukvård, vaccination, konsultativ verksamhet med personalbemanning,
Address
Ölmevägen 30
Email
info@aspirus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 594 | 998 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 492 | 136 | −11 | −2 | −1 | −1 | −1 | −4 | 127 | −110 |
| Depreciation & amort. | −60 | −75 | −72 | −15 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 432 | 61 | −83 | −17 | −1 | −1 | −1 | −4 | 127 | −110 |
| Net financials | −6 | −4 | −2 | — | — | — | — | — | — | — |
| Profit before tax | 427 | 58 | −86 | −18 | −1 | −1 | −1 | −4 | 127 | −110 |
| Tax | −94 | −13 | 47 | −73 | −0 | −0 | −0 | −0 | −26 | −0 |
| Net profit | 333 | 45 | −39 | −91 | −1 | −1 | −1 | −4 | 101 | −110 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 404 | 114 | 126 | 74 | 277 | 276 | 279 | 274 | 401 | 288 |
| Equity | 362 | 407 | 368 | 277 | 276 | 275 | 274 | 269 | 370 | 260 |
| Long-term debt | 111 | 93 | 93 | 93 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | −69 | −386 | 335 | 296 | 1 | 2 | 5 | 4 | 31 | 28 |
| Total debt | 42 | −293 | 428 | 389 | 1 | 2 | 5 | 4 | 31 | 28 |
EBITDA margin
-11.0%
This company
15.8%
Market median
-170% vs market
20152024
Equity ratio
90.3%
This company
38.2%
Market median
+136% vs market
20152024
Return on equity
-42.3%
This company
18.4%
Market median
-330% vs market
20152024
Net profit margin
-11.0%
This company
8.1%
Market median
-236% vs market
20152024
Asset turnover
3.47×
This company
1.12×
Market median
+210% vs market
20152024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aspirus Hälsovård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svetlana Abulebda | Deputy Board Member | 0 companies |
| Belal Khalid Abulebda | Board of Directors | 0 companies |
| Zen Amery | Deputy Board Member | 0 companies |